
ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV (ARYD) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
ARYD · free cash flow · updated Jun 9, 2026
Core FCF metrics
ARYD · FCF · TTM · margin & CAGRFree cash flow was −$725,858 for FY2023 (fiscal year ending 2023-12-31), down 49.6% year-over-year
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
ARYD · P/FCF · FCF yield · FCF per shareARYA Sciences Acquisition Corp IV (ARYD) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.
FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.
Cash flow statement summary
ARYD · cash flow statement · operating / investing / financingFor FY2023, ARYA Sciences Acquisition Corp IV generated −$0.7M in operating cash flow and spent 0M in capital expenditures, yielding −$0.7M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Financial Services)
About Free Cash Flow & Methodology
ARYA Sciences Acquisition Corp IV (ARYD) reported free cash flow of −$725,858 for FY2023 (fiscal year ending 2023-12-31), down 49.6% year-over-year.
Based on available data, ARYA Sciences Acquisition Corp IV has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $2,323 in FY2020.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
ARYD free cash flow · 8 questionsARYA Sciences Acquisition Corp IV free cash flow was −$725,858 for FY2023, down 49.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.0M.
▸ Source: FMP /cash-flow-statement · US GAAP · ARYA Sciences Acquisition Corp IV · ARYA Sciences Acquisition Corp IV SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026